Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine (Episode 2)

Related posts

Paper from BHI Therapeutic Sciences and Blue Horizon International, Slovakia Published in the Journal of Clinical Medicine Research

by bluehorizon
6 years ago

Brian Mehling, MD, (R) and Dongecheng Wu, MD, Ph.D., (L) during the stem cell applications at BHI Jamaica.

by bluehorizon
7 years ago

Blue Horizon International Therapeutic Sciences to exhibit at World Congress on Anti-Aging Medicine in Las Vegas

by bluehorizon
8 years ago
Exit mobile version